Information Provided By: 
Fly News Breaks for June 11, 2015
PODD
Jun 11, 2015 | 06:47 EDT
Piper Jaffray recommends using any weakness in shares of Insulet after the company disclosed receipt of a Warning Letter from the FDA as a buying opportunity. Piper is not surprised by the letter given Insulet's past quality issues and does not expect the business to be impacted. It keeps an Overweight rating on the stock with a $36 price target.
News For PODD From the Last 2 Days
There are no results for your query PODD
